Prenuvo, a full-body imaging company, raised $120 million in a Series B funding round.
Venture capital firms Forerunner Ventures and Left Lane Capital co-led the round, which was announced Thursday. Venture firm Felicis, a previous investor in the company, also participated.
Related: AI isn't showing ROI—yet. Here's where there's promise.
Prenuvo uses artificial intelligence and medical imaging scans with the goal of identifying potential health concerns faster than other types of preventive medicine. The scans can identify a number of conditions including cancer, aneurysm and gallstones.
The company offers full body MRI scans directly to consumers for around $2,500 per scan. Prenuvo also partners with employers to give employees access to the scans at lower out-of-pocket costs.
Prenuvo, which operates 17 clinics in North America, will use the round to grow and scale its operations and open additional locations, according to a news release.
The round comes as a growing number of companies are competing for market share in the full-body MRI space. Other companies include Ezra, which sells a full body MRI scan for cancer screening and Q Bio, a startup backed by well-known venture capital firms Khosla Ventures, Andreessen Horowitz and Founders Fund.
The company last announced it raised $70 million in an October 2022 Series A funding round.
